No Data
Deutsche Bank AG UK Regulatory Announcement: Value per Security
Wall Street advisors expect the Trade facilitation Business to heat up during the Trump era.
Wall Street merger consultants indicate that anticipated regulatory relaxation is likely to drive merger and acquisition activity and initial public offerings over the next year, as companies are beginning to revive their Trade playbooks. Christina Minnis, head of Global Crediting and Global Business at Goldman Sachs, stated that given Donald Trump's policy commitments during his presidential campaign, "I think the market might perceive that merger and acquisition activity in the USA could become somewhat stronger." Minnis expressed on Tuesday that due to uncertainties surrounding potential tariffs in the USA, she expects "Europe will be more reserved," but overall, Trade activity should increase before the summer. "Since the election, the number of transactions has been increasing."
J.P. Morgan Maintains Deutsche Bank(DB.US) With Buy Rating, Raises Target Price to $22.21
The impact of tariffs on inflation may only be temporary, but the Federal Reserve does not dare to say so.
Trump's tariff barrage may stimulate the Federal Reserve to make responses that the new president does not like. The president-elect has promised to impose tariffs on imported commodities after taking office. During his first term, researchers at the Federal Reserve envisioned a similar scenario and concluded that inflation would accelerate but not for too long. Since tariffs are ultimately seen as dragging on the economy, they believe that lowering interest rates is the best remedy. However, there are two major obstacles to taking this approach now. Firstly, the Federal Reserve has not completely stemmed the rising cost of living after the epidemic. Secondly, the Federal Reserve has previously misjudged inflation as a 'temporary phenomenon', and has therefore suffered
MFE-MediaForEurope in Talks for 3.4 Billion-Euro Loan for ProSiebensat1 Bid, Il Messaggero Says
Decibel Receives Final TSX Venture Exchange Acceptance For AgMedica Acquisition And Debenture Conversion
